Jason Drew Smith - General Counsel at UroGen Pharma Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Issuer Symbol
URGN on Nasdaq
All Insider Reports
All Insider Reports

Jason Drew Smith - trading volume in the past year for UroGen Pharma Ltd.

Holdings reported by Jason Drew Smith for UroGen Pharma Ltd.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 55,588 $1,094,527 $19.69 03 Feb 2026 Direct
Restricted Stock Units 32,609 31 Jan 2026 Direct Ordinary Shares

Transactions reported by Jason Drew Smith for UroGen Pharma Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.